ClinicalTrials.Veeva

Menu

Early Detection of Clinical Deterioration in Patients With COVID-19 Using Machine Learning

U

University Hospital Tuebingen

Status

Unknown

Conditions

Covid19

Treatments

Other: Machine based evaluation
Other: Machine learning

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The aim of this study is to use artificial intelligence in the form of machine learning analysing vital signs as well as symptoms of patients suffering from Covid19 to identify predictors of disease progression and severe course of disease.

Enrollment

1,000 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Written informed consent
  • Age >= 18 years
  • Detection of SARS-CoV2 within the past 5 days

Exclusion criteria

  • Inability to measure vital parameters and document symptoms

Trial design

1,000 participants in 2 patient groups

Training cohort
Description:
Randomly selection of 80% of the study population. The machine learning algorithm is trained on this dataset
Treatment:
Other: Machine learning
Validation cohort
Description:
Randomly selection of 20% of the study population. The machine learning algorithm which was trained on the basis of the training data cohort is validated on the validation cohort.
Treatment:
Other: Machine based evaluation

Trial contacts and locations

1

Loading...

Central trial contact

Annika Buchholz, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems